CO6270316A2 - Esterilizante quimico para el control de la poblacion de perros machos adultos que comprende un gluconato mineral y un aminoacido - Google Patents

Esterilizante quimico para el control de la poblacion de perros machos adultos que comprende un gluconato mineral y un aminoacido

Info

Publication number
CO6270316A2
CO6270316A2 CO10050344A CO10050344A CO6270316A2 CO 6270316 A2 CO6270316 A2 CO 6270316A2 CO 10050344 A CO10050344 A CO 10050344A CO 10050344 A CO10050344 A CO 10050344A CO 6270316 A2 CO6270316 A2 CO 6270316A2
Authority
CO
Colombia
Prior art keywords
dog
population
amino acid
control
dogs
Prior art date
Application number
CO10050344A
Other languages
English (en)
Inventor
Ming Wang
Original Assignee
Fahim Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fahim Technology Inc filed Critical Fahim Technology Inc
Publication of CO6270316A2 publication Critical patent/CO6270316A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/315Zinc compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Feed For Specific Animals (AREA)

Abstract

Una composicion quimica para uso en el control de la poblacion de perros vagabundos, sexualmente maduros, El esterilizante quimico es inyectado de una manera tal que se preservan la apariencia y las caracteristicas sexuales secundarias masculinas del perro en un grado tal que el perro mantiene su posicion en la jerarquia de los perros vagabundos mientras que no contribuye a la cantidad de cachorros engendrados. Una reduccion de la cantidad de perros vagabundos reduce la cantidad de victimas humanas de rabia adquiridas por mordeduras de perros. Debido a que la apariencia y la naturaleza del perro esterilizado permanecen sustancialmente inalteradas, la composicion quimica es aceptable para la comunidad humana que el perro habita.
CO10050344A 2007-09-28 2010-04-28 Esterilizante quimico para el control de la poblacion de perros machos adultos que comprende un gluconato mineral y un aminoacido CO6270316A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/863,758 US20090088471A1 (en) 2007-09-28 2007-09-28 Chemical sterilant for adult male dog population control with concomitant reduction in human dog-bite acquired rabies

Publications (1)

Publication Number Publication Date
CO6270316A2 true CO6270316A2 (es) 2011-04-20

Family

ID=40089865

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10050344A CO6270316A2 (es) 2007-09-28 2010-04-28 Esterilizante quimico para el control de la poblacion de perros machos adultos que comprende un gluconato mineral y un aminoacido

Country Status (12)

Country Link
US (1) US20090088471A1 (es)
EP (1) EP2192897A1 (es)
CN (1) CN101888838A (es)
AR (1) AR068581A1 (es)
BR (1) BRPI0804518A2 (es)
CL (1) CL2008002909A1 (es)
CO (1) CO6270316A2 (es)
MX (1) MX2010003474A (es)
PA (1) PA8797601A1 (es)
PE (1) PE20091031A1 (es)
RU (1) RU2455000C2 (es)
WO (1) WO2009045337A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012204526B2 (en) 2011-01-03 2016-05-19 California Institute Of Technology High density epidural stimulation for facilitation of locomotion, posture, voluntary movement, and recovery of autonomic, sexual, vasomotor, and cognitive function after neurological injury
US9393409B2 (en) 2011-11-11 2016-07-19 Neuroenabling Technologies, Inc. Non invasive neuromodulation device for enabling recovery of motor, sensory, autonomic, sexual, vasomotor and cognitive function
HUE044036T2 (hu) * 2012-08-23 2019-09-30 Senestech Inc Nõstény patkányok reprodukciós kapacitásának csökkentésére szolgáló készítmények és módszerek
US20140271716A1 (en) 2013-03-15 2014-09-18 Ark Sciences, Inc. Intra-testicular Injection of Immunogens
EP3049148B1 (en) 2013-09-27 2020-05-20 The Regents Of The University Of California Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects
EP3974021B1 (en) 2017-06-30 2023-06-14 ONWARD Medical N.V. A system for neuromodulation
US11992684B2 (en) 2017-12-05 2024-05-28 Ecole Polytechnique Federale De Lausanne (Epfl) System for planning and/or providing neuromodulation
EP3653256B1 (en) 2018-11-13 2022-03-30 ONWARD Medical N.V. Control system for movement reconstruction and/or restoration for a patient
EP3695878B1 (en) 2019-02-12 2023-04-19 ONWARD Medical N.V. A system for neuromodulation
DE19211698T1 (de) 2019-11-27 2021-09-02 Onward Medical B.V. Neuromodulation system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156427A (en) * 1976-01-23 1979-05-29 The Curators Of The University Of Missouri Injectable male animal sterilant for selectively controlling the function of testes
US4339438A (en) * 1976-01-23 1982-07-13 The Curators Of The University Of Missouri Injectable male animal sterilant for selectively controlling the function of testes
US4937234A (en) * 1988-08-10 1990-06-26 Fahim Mostafa S Minerals in bioavailable form
US5070080A (en) * 1988-08-10 1991-12-03 Fahim Mostafa S Method of inhibiting generation, maturation, motility and viability of sperm with minerals in bioavailable form
US5372822A (en) * 1994-03-07 1994-12-13 Fahim; Mostafa S. Chemical castration
US7276535B1 (en) * 2003-04-14 2007-10-02 Technology Transfer, Inc. Intratesticular injection of chemical sterilant
US7125385B1 (en) * 2003-04-14 2006-10-24 Technology Transfer, Inc. Instrument for determining intratesticular dose and method for determining a dose

Also Published As

Publication number Publication date
WO2009045337A1 (en) 2009-04-09
CL2008002909A1 (es) 2009-09-04
PE20091031A1 (es) 2009-08-19
US20090088471A1 (en) 2009-04-02
PA8797601A1 (es) 2010-05-26
AR068581A1 (es) 2009-11-18
BRPI0804518A2 (pt) 2011-08-30
MX2010003474A (es) 2010-08-04
RU2455000C2 (ru) 2012-07-10
EP2192897A1 (en) 2010-06-09
CN101888838A (zh) 2010-11-17
RU2010116777A (ru) 2011-11-10

Similar Documents

Publication Publication Date Title
CO6270316A2 (es) Esterilizante quimico para el control de la poblacion de perros machos adultos que comprende un gluconato mineral y un aminoacido
CO6511222A2 (es) Derivado de idenona y composición famacéutica que comprende el mismo
UY28757A1 (es) Compuestos de pirazolina substituidos, su preparación y su uso como medicamentos
MD4577B1 (ro) Compoziţii masticabile de uz veterinar care conţin agent activ izoxazolinic şi utilizarea acestora în tratamentul sau prevenirea unei infestări sau infecţii parazitare
CL2010001260A1 (es) Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis.
CR20110609A (es) Composicion antimicrobiana y metodos relacionados de uso
PE20210924A1 (es) Composiciones para animales, y sus usos
CL2008000445A1 (es) Metodo para la profilaxis y el tratamiento de una infeccion subclinica por circovirus porcino tipo 2 (pcv2) en un animal individual o un grupo de animales que comprende administrar un antigeno del pcv2; uso del antigeno pcv2 para la profilaxis de un
CL2009000498A1 (es) Compuestos derivados de benzo [f][1,7]naftiridin sustituidos, moduladores de receptor toll; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedad infecciosa, inflamatoria, dermatologica, respiratoria o inmune.
BR112014008255A8 (pt) Composições antimicrobianas e métodos empregando as mesmas
CU20120171A7 (es) Triazolopiridinas sustituidas
BR112015026077A8 (pt) barra de sabão, método de redução de bactérias gram positivas e uso de uma barra de sabão
AR061646A1 (es) Profarmacos de penem
CO6382113A2 (es) Compuestos quimicos
EA201171431A1 (ru) Применение комбинации d-аспарагиновой и l-аспарагиновой кислот или их солей для лечения мужского бесплодия
ECSP099734A (es) Composición farmaceutica que comprende la combinación de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante
UY31737A (es) Composiciones farmacéuticas que contienen una sal de sulfato de hidrógeno
CL2011002651A1 (es) Composicion veterinaria que comprende dipropionato de imidocarb, cianocobalamina vitamina b12 y un vehiculo farmaceuticamente aceptable; y su uso para tratar o prevenir enfermedades infecciosas parasitarias en ganado.
AR071779A1 (es) Formulaciones de emulsion narcotica para el tratamiento del dolor quirurgico
AR051429A1 (es) Composicion farmaceutica ozonizada y metodos para obtenerla
NI201200196A (es) Agentes terapéuticos 976
ES2422293T3 (es) Opiopatias
ES2555785T3 (es) Remedio o preventivo para esquizofrenia
DOP2016000008A (es) Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
ES2337005R (es) Compuestos de pirazolina azepan o azocansustituidos, su preparacion y su uso como medicamentos.

Legal Events

Date Code Title Description
FC Application refused